Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum

NCT02326740 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT02326740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02326740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Gevokizumab in Treating Active Ulcers of Pyoderma Gangrenosum
Lead sponsor
XOMA (US) LLC
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2014
Completion date
March 31, 2016
Enrollment
9 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

pyoderma gangrenosum